Scientific Committee

Stefan Glück

  • Designation: VP and Franchise Head, Global Medical Affairs, Oncology - Haematology, REGENERON REGN which ended DEC 2021
  • Country: USA


Stefan Glück, MD, Ph.D., FRCPC is a medical oncologist and was V.P. Global Medical Affairs, at Celgene Corporation from October 2014 until December 2019. He oversaw oncology activities worldwide, as well as the Immune-Oncology program in solid tumors and hematology. He contributed to activities of Celgene around Early Assets. In early 2020, when the pandemic hit, he joined remotely REGENERON as VP and Franchise Head, Global Medical Affairs, Oncology - Haematology until July 2021. During these 16 months at GMA, he built a team of 27 colleagues virtually and actually never met anyone in person.

At present, his focus is on helping small companies to get their innovative products to patients, hopefully prolonging, and improving their lives, and potentially leading the efforts to cure cancer for many.

He previously served as a Sylvester Professor in the Department of Medicine at Miller School of Medicine, University of Miami, Florida until September 2014. From 2003–2008, he was the Clinical Director of the Braman Family Breast Cancer Institute at UM. His clinical practice focussed on patients with breast cancer and during his hospital service, all malignant diseases including hematology and solid tumors. He enjoyed teaching fellows, residents, and medical MD/Ph.D. students in hematology and oncology, bedside, and in-class courses.

He has authored or co-authored over 275 articles. In addition, Dr. Glück has written or co-written several book chapters, and numerous abstracts and has presented more than 500 papers at national and international meetings.



Don't miss our future updates!

Get in Touch